title: CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues.
abstract: CD40 is a 48 Kd integral membrane protein expressed by cells of B cells, origin, dentritic cells, monocytes, epithelial cells, endothelial cells and tumor cells including carcinomas, B cell lymphomas/leukemias and Hodgkin and Reed-Sternberg (HRS) cells of Hodgkin's disease (HD). CD40 has been clustered as a member of the nerve growth factor (NGF)/tumor necrosis factor (TNF) receptor superfamily with the corresponding counterstructure, the CD40 ligand (L) being mainly expressed by activated CD4+ T cells, but also some activated CD8+ T cells, basophils, eosinophils, mast cells and stromal cells. CD40L shares significant amino acid homology with TNF particularly in its extracellular domain ("TNF homology region") and is therefore viewed as a member of the TNF ligand superfamily. Binding of CD40L+ T cells to CD40+ B cells is thought to play a major role in T cell-dependent B cell activation, B cell proliferation, Ig isotype switching, memory B cell formation and rescue of B cells from apoptotic death in germinal centers. Mutations of the CD40L gene have been associated with the X-linked hyper-IgM immunodeficiency syndrome, pointing to the critical role of the CD40/CD40L interaction in the T cell-B cell interplay. Accordingly, expression of CD40 by human lympho-hematopoietic tumors has been shown in most of the B cell neoplasias, H-RS cells and HD and some carcinomas. In contrast, CD40L+ tumor cells are almost invariably restricted to CD4+/CD8- T cell lymphomas. Overall, functional CD40/CD40L interactions appear to be critical for cellular activation signals during immune responses and neoplastic tumor cell growth. The understanding of the biology of CD40L has improved our diagnostic and therapeutic repertoire in the management of several human diseases, including CD40+ tumors.
authors.affiliation: Department of Internal Medicine III, University of Ulm Medical Center, Germany.
authors.forename: H J
authors.initials: HJ
authors.lastname: Gruss
authors.forename: F
authors.initials: F
authors.lastname: Herrmann
authors.forename: V
authors.initials: V
authors.lastname: Gattei
authors.forename: A
authors.initials: A
authors.lastname: Gloghini
authors.forename: A
authors.initials: A
authors.lastname: Pinto
authors.forename: A
authors.initials: A
authors.lastname: Carbone
mesh_terms: D000818:Animals; D019013:CD40 Antigens / Q000378:metabolism*; D023201:CD40 Ligand; D019337:Hematologic Neoplasms / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D008223:Lymphoma / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000378:metabolism*
chemical_list: D019013:CD40 Antigens; D008024:Ligands; D008562:Membrane Glycoproteins; D023201:CD40 Ligand